中华生物医学工程杂志2023,Vol.29Issue(6) :650-655.DOI:10.3760/cma.j.cn115668-20231007-00039

血清高迁移率族蛋白B1、胱抑素C及白细胞介素-17联合检测对多发性骨髓瘤患者肾损伤的诊断价值

The diagnostic value of combined detection of serum high mobility group protein B1,Cystatin C and Interleukin-17 for renal injury in patients with multiple myeloma

杨春燕 黄倩 程盼盼 陈璐璐 贾燕 张顥
中华生物医学工程杂志2023,Vol.29Issue(6) :650-655.DOI:10.3760/cma.j.cn115668-20231007-00039

血清高迁移率族蛋白B1、胱抑素C及白细胞介素-17联合检测对多发性骨髓瘤患者肾损伤的诊断价值

The diagnostic value of combined detection of serum high mobility group protein B1,Cystatin C and Interleukin-17 for renal injury in patients with multiple myeloma

杨春燕 1黄倩 1程盼盼 1陈璐璐 1贾燕 1张顥1
扫码查看

作者信息

  • 1. 济宁医学院附属医院血液科,济宁 272007
  • 折叠

摘要

探讨血清高迁移率族蛋白B1(HMGB1)、胱抑素C(CysC)及白细胞介素(IL)-17联合检测对多发性骨髓瘤(MM)患者肾损伤的诊断价值.研究发现血清HMGB1、CysC及IL-17在MM患者中异常高表达,且与病情进展及肾损伤存在密切联系,三者联合检测诊断MM患者并发肾损伤的效能较高.

Abstract

To investigate the diagnostic value of combined detection of serum high mobility group protein B1(HMGB1),cystatin C(CysC)and interleukin(IL)-17 for renal injury in patients with multiple myeloma(MM).The study shows abnormal high expression of serum HMGB1,CysC and IL-17 in MM patients is closely related to the progression of the disease and renal injury.The combined detection of the three has a high efficiency in the diagnosis of renal injury in MM patients.

关键词

多发性骨髓瘤/肾损伤/高迁移率族蛋白B1/胱抑素C/白细胞介素-17

Key words

Multiple myeloma/Kidney injury/High mobility group protein B1/Cystatin C/Interleukin-17

引用本文复制引用

基金项目

山东省自然科学基金青年项目(ZR2022OH239)

出版年

2023
中华生物医学工程杂志
中华医学会 广州医学院

中华生物医学工程杂志

CSTPCD
影响因子:0.416
ISSN:1674-1927
参考文献量6
段落导航相关论文